Photo taken from Diego Dibitetto/LinkedIn
May 27, 2024, 04:00
Diego Dibitetto: H2AX downregulation is a new mechanism of chemotherapy resistance in BRCA-deficient tumors
Diego Dibitetto, Postdoc fellow at the University of Bern, shared a post on LinkedIn:
“Our new paper is finally out!! H2AX downregulation is a new mechanism of chemotherapy resistance in BRCA-deficient tumors. Thanks to all the people involved Jos Jonkers, Alessandro Sartori, Josep Forment, Massimo Lopes, Claus Storgaard Sørensen, it was such a joy working with you!”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 22, 2024, 18:02
Dec 22, 2024, 17:54
Dec 22, 2024, 17:51
Dec 22, 2024, 17:47
Dec 22, 2024, 17:44
Dec 22, 2024, 17:39
Dec 22, 2024, 17:36
Dec 22, 2024, 17:32
Dec 22, 2024, 17:18